DAVID HARPER, PH.D.
Corporate Board Profile
Tech Score:
0
/100
← Back to All Directors
Armata Pharmaceuticals, Inc.
Filing Date
Source Excerpt
2014-11-25
David Harper, Ph.D. Includes options to purchase 600,000 shares of common stock.
Data sourced from SEC filings. Last updated: 2025-10-12